{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T02:05:05Z","timestamp":1781143505409,"version":"3.54.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T00:00:00Z","timestamp":1726185600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T00:00:00Z","timestamp":1726185600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100018935","name":"Universit\u00e4tsklinikum Erlangen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100018935","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:italic>Mycoplasma pneumoniae<\/jats:italic>, a frequent respiratory pathogen, can cause neurological disease manifestations. We here present a case of <jats:italic>M. pneumoniae<\/jats:italic> as cause of meningitis and occurrence of an intracranial abscess as a complication of mastoiditis with septic cerebral venous sinus thrombosis in a patient with multiple sclerosis on anti-CD20 therapy.<\/jats:p>","DOI":"10.1007\/s10096-024-04935-3","type":"journal-article","created":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T02:02:39Z","timestamp":1726192959000},"page":"2227-2231","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Meningitis and intracranial abscess due to Mycoplasma pneumoniae in a B cell-depleted patient with multiple sclerosis"],"prefix":"10.1007","volume":"43","author":[{"given":"Dominik","family":"Mad\u017ear","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian T.","family":"Nickel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veit","family":"Rothhammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Goelitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Gei\u00dfd\u00f6rfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Dumke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,13]]},"reference":[{"key":"4935_CR1","doi-asserted-by":"publisher","unstructured":"Davis JS, Ferreira D, Paige E, Gedye C, Boyle M (2020) Infectious complications of biological and small molecule targeted immunomodulatory therapies. Clin Microbiol Rev 33(3). https:\/\/doi.org\/10.1128\/CMR.00035-19","DOI":"10.1128\/CMR.00035-19"},{"issue":"9805","key":"4935_CR2","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1016\/S0140-6736(11)61649-8","volume":"378","author":"L Kappos","year":"2011","unstructured":"Kappos L, Li D, Calabresi PA et al (2011) Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial. Lancet 378(9805):1779\u20131787","journal-title":"Lancet"},{"issue":"3","key":"4935_CR3","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1056\/NEJMoa1601277","volume":"376","author":"SL Hauser","year":"2017","unstructured":"Hauser SL, Bar-Or A, Comi G et al (2017) Ocrelizumab versus interferon Beta-1a in relapsing multiple sclerosis. N Engl J Med 376(3):221\u2013234","journal-title":"N Engl J Med"},{"issue":"4","key":"4935_CR4","doi-asserted-by":"publisher","first-page":"ofx204","DOI":"10.1093\/ofid\/ofx204","volume":"4","author":"PA Steininger","year":"2017","unstructured":"Steininger PA, Bobinger T, Dietrich W et al (2017) Two cases of severe tick-borne encephalitis in rituximab-treated patients in germany: implications for diagnosis and prevention. Open Forum Infect Dis 4(4):ofx204","journal-title":"Open Forum Infect Dis"},{"issue":"12","key":"4935_CR5","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1093\/cid\/ciu189","volume":"58","author":"A Grankvist","year":"2014","unstructured":"Grankvist A, Andersson PO, Mattsson M et al (2014) Infections with the tick-borne bacterium \u201cCandidatus Neoehrlichia mikurensis\u201d mimic noninfectious conditions in patients with B cell malignancies or autoimmune diseases. Clin Infect Dis 58(12):1716\u20131722","journal-title":"Clin Infect Dis"},{"issue":"3","key":"4935_CR6","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s15010-015-0859-6","volume":"44","author":"E Nulens","year":"2016","unstructured":"Nulens E, Van Praet J, Selleslag D et al (2016) A disseminated Mycoplasma hominis infection in a patient with an underlying defect in humoral immunity. Infection 44(3):379\u2013381","journal-title":"Infection"},{"issue":"2","key":"4935_CR7","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1128\/JCM.02990-13","volume":"52","author":"P Deetjen","year":"2014","unstructured":"Deetjen P, Maurer C, Rank A, Berlis A, Schubert S, Hoffmann R (2014) Brain abscess caused by Ureaplasma urealyticum in an adult patient. J Clin Microbiol 52(2):695\u2013698","journal-title":"J Clin Microbiol"},{"issue":"12","key":"4935_CR8","first-page":"2517","volume":"70","author":"PN Britton","year":"2020","unstructured":"Britton PN, Dale RC, Blyth CC et al (2020) Causes and clinical features of childhood encephalitis: a multicenter. Prospective Cohort Study Clin Infect Dis 70(12):2517\u20132526","journal-title":"Prospective Cohort Study Clin Infect Dis"},{"key":"4935_CR9","doi-asserted-by":"publisher","first-page":"2751","DOI":"10.3389\/fmicb.2018.02751","volume":"9","author":"R D'Alonzo","year":"2018","unstructured":"D\u2019Alonzo R, Mencaroni E, Di Genova L, Laino D, Principi N, Esposito S (2018) Pathogenesis and treatment of neurologic diseases associated with mycoplasma pneumoniae infection. Front Microbiol 9:2751","journal-title":"Front Microbiol"},{"key":"4935_CR10","doi-asserted-by":"publisher","first-page":"974","DOI":"10.3389\/fmicb.2016.00974","volume":"7","author":"S Pereyre","year":"2016","unstructured":"Pereyre S, Goret J, B\u00e9b\u00e9ar C (2016) Mycoplasma pneumoniae: current knowledge on macrolide resistance and treatment. Front Microbiol 7:974","journal-title":"Front Microbiol"},{"key":"4935_CR11","doi-asserted-by":"publisher","unstructured":"Dumke R, Ziegler T (2019) Long-Term Low Rate of Macrolide-Resistant Mycoplasma pneumoniae Strains in Germany. Antimicrob Agents Chemother 63(5). https:\/\/doi.org\/10.1128\/AAC.00455-19","DOI":"10.1128\/AAC.00455-19"},{"key":"4935_CR12","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.ijid.2014.07.014","volume":"29","author":"R Dumke","year":"2014","unstructured":"Dumke R, Stolz S, Jacobs E, Juretzek T (2014) Molecular characterization of macrolide resistance of a Mycoplasma pneumoniae strain that developed during therapy of a patient with pneumonia. Int J Infect Dis 29:197\u2013199","journal-title":"Int J Infect Dis"},{"issue":"4","key":"4935_CR13","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1128\/CMR.00007-10","volume":"23","author":"R Nau","year":"2010","unstructured":"Nau R, S\u00f6rgel F, Eiffert H (2010) Penetration of drugs through the blood-cerebrospinal fluid\/blood-brain barrier for treatment of central nervous system infections. Clin Microbiol Rev 23(4):858\u2013883","journal-title":"Clin Microbiol Rev"},{"issue":"2","key":"4935_CR14","doi-asserted-by":"publisher","first-page":"E31","DOI":"10.1086\/318446","volume":"32","author":"M Socan","year":"2001","unstructured":"Socan M, Ravnik I, Bencina D, Dovc P, Zakotnik B, Jazbec J (2001) Neurological symptoms in patients whose cerebrospinal fluid is culture- and\/or polymerase chain reaction-positive for Mycoplasma pneumoniae. Clin Infect Dis 32(2):E31\u2013E35","journal-title":"Clin Infect Dis"},{"key":"4935_CR15","doi-asserted-by":"publisher","unstructured":"Sarathchandran P, Al Madani A, Alboudi AM, Inshasi J (2018) Mycoplasma pneumoniae infection presenting as stroke and meningoencephalitis with aortic and subclavian aneurysms without pulmonary involvement. BMJ Case Rep 2018. https:\/\/doi.org\/10.1136\/bcr-2017-221831","DOI":"10.1136\/bcr-2017-221831"},{"key":"4935_CR16","doi-asserted-by":"publisher","first-page":"4479","DOI":"10.2147\/IDR.S371771","volume":"15","author":"Y Dong","year":"2022","unstructured":"Dong Y, He Y, Zhou X et al (2022) Diagnosis of mycoplasma hominis meningitis with metagenomic next-generation sequencing: a case report. Infect Drug Resist 15:4479\u20134486","journal-title":"Infect Drug Resist"}],"container-title":["European Journal of Clinical Microbiology &amp; Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-024-04935-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-024-04935-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-024-04935-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T14:04:30Z","timestamp":1730729070000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-024-04935-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,13]]},"references-count":16,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["4935"],"URL":"https:\/\/doi.org\/10.1007\/s10096-024-04935-3","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,13]]},"assertion":[{"value":"4 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}